Skip to main content
PLOS One logoLink to PLOS One
. 2024 Dec 30;19(12):e0316871. doi: 10.1371/journal.pone.0316871

Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials

Fitriyadi Kusuma, Glenardi Glenardi, Ghea Mangkuliguna, Hariyono Winarto, Gatot Purwoto, Tofan Widya Utami, Tricia Dewi Anggraeni
PMCID: PMC11684688  PMID: 39775309

There is an error in affiliation 1 for authors Fitriyadi Kusuma, Glenardi Glenardi, Hariyono Winarto, Gatot Purwoto, Tofan Widya Utami and Tricia Dewi Anggraeni. The correct affiliation 1 is: Faculty of Medicine Universitas Indonesia, Department of Obstetrics and Gynecology, Division of Oncology Gynecology, Dr. Cipto Mangunkusumo Hospital, Greater Jakarta, DKI Jakarta, Indonesia.

Reference

  • 1.Kusuma F, Glenardi G, Mangkuliguna G, Winarto H, Purwoto G, Utami TW, et al. (2024) Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials. PLOS ONE 19(8): e0307800. doi: 10.1371/journal.pone.0307800 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from PLOS ONE are provided here courtesy of PLOS

RESOURCES